Averna Therapeutics
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $39M
Investors
- 10
About Averna Therapeutics
Founded in 2022 and based in New York, US, Exsilio Therapeutics Inc. operates as a biotechnology company that develops genomic medicines for the treatment of various autoimmune and genetic diseases. In June 2024, Exsilio Therapeutics Inc.P. Morgan Alternative Asset Management, CRISPR Therapeutics AG, Innovation Endeavors, Invus, Arc Ventures, and Deep Insight. The firm develops and offers genomic medicines using lipid nanoparticles to address a wide range of diseases, including genetic disorders, cancer, and autoimmune conditions. Their technology leverages naturally occurring genetic elements to insert new genes into cells via RNA intermediate templates. This process is enhanced through predictive in silico modeling and laboratory experimentation. The medicines are encoded in mRNA, enabling delivery through non-viral platforms that are safe, efficient, scalable, and allow for redosing. Exsilio aims to provide curative treatments by inserting therapeutic genes into safe harbor sites within DNA.
Who invested in Averna Therapeutics
10 investors across 1 round
See all investors in Averna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 8, 2024
Amount
$39M
Investors
Questions about Averna Therapeutics
Who invested in Averna Therapeutics?
Averna Therapeutics has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Averna Therapeutics raised?
Averna Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Averna Therapeutics last raise money?
Averna Therapeutics's most recent round on record is a Series A, in Apr 2024.
What does Averna Therapeutics do?
Founded in 2022 and based in New York, US, Exsilio Therapeutics Inc.
Where is Averna Therapeutics headquartered?
Averna Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Averna Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Averna Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Averna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.